{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:47:13Z","timestamp":1785822433471,"version":"3.56.0"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE), affecting more than 50% of SLE patients and remaining a leading cause of end-stage renal disease (ESRD) worldwide. Current standard therapies\u2014glucocorticoids combined with conventional immunosuppressants\u2014fail to achieve sustained remission in 30%\u201340% of patients and are associated with substantial toxicities, including infections, osteoporosis, and cardiovascular disease. The chemokine system, composed of small secreted proteins and their G protein-coupled receptors (GPCRs), plays a central role in LN pathogenesis by orchestrating pathogenic immune cell infiltration, renal inflammation, and progressive fibrosis. This review synthesizes preclinical and clinical evidence establishing the chemokine network as a rational therapeutic target in LN. We first outline the clinical burden of LN and the limitations of existing therapies, followed by a systematic overview of chemokine biology (classification, structural interactions, and leukocyte trafficking functions). Next, we dissect the pathogenic roles of chemokines in LN, focusing on their secretion by resident renal cells, regulation of immune cell infiltration, and association with renal fibrosis. Subsequently, we evaluate therapeutic advances targeting chemokines, including small-molecule antagonists, monoclonal antibodies, and upstream pathway interventions, while discussing translational challenges (e.g., preclinical-clinical disconnect, complexity of target selection, safety concerns). Finally, we highlight emerging technologies, opportunities for personalized medicine, and long-term research priorities to facilitate the development of chemokine-based therapeutic strategies for LN.<\/jats:p>","DOI":"10.3389\/fphar.2026.1867426","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:36:29Z","timestamp":1785821789000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The chemokine network in lupus nephritis: pathogenesis, targeted therapies, and future directions"],"prefix":"10.3389","volume":"17","author":[{"given":"Chengye","family":"Wang","sequence":"first","affiliation":[{"name":"Queen Mary School, Nanchang University","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.3390\/biomedicines13123084","article-title":"Immunosuppressive therapy in pediatric kidney transplantation: evolution, current practices, and future directions","volume":"13","author":"Al Riyami","year":"2025","journal-title":"Biomedicines"},{"key":"B2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1053\/j.ackd.2019.08.009","article-title":"Membranous lupus nephritis: a clinical review","volume":"26","author":"Almaani","year":"2019","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ki.2011.217","article-title":"Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis","volume":"80","author":"Anders","year":"2011","journal-title":"Kidney Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/cvr\/cvn029","article-title":"Understanding the immunoangiostatic CXC chemokine network","volume":"78","author":"Balestrieri","year":"2008","journal-title":"Cardiovasc Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1007\/s10787-025-01871-2","article-title":"Chemokine receptor type-5: a key regulator of immunity, disease pathogenesis, and emerging therapeutic target","volume":"33","author":"Bambal","year":"2025","journal-title":"Inflammopharmacology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1043117","DOI":"10.3389\/fcell.2022.1043117","article-title":"3D organ-on-a-chip: the convergence of microphysiological systems and organoids","volume":"10","author":"Baptista","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e00262","DOI":"10.1002\/prp2.262","article-title":"Biased small-molecule ligands for selective inhibition of HIV-1 cell entry via CCR5","volume":"4","author":"Berg","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/pro.3744","article-title":"Structural basis of chemokine and receptor interactions: key regulators of leukocyte recruitment in inflammatory responses","volume":"29","author":"Bhusal","year":"2020","journal-title":"Protein Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e70560","DOI":"10.14814\/phy2.70560","article-title":"Distinct lung functional, histological and cell senescence signatures in the single and repetitive bleomycin mouse models of idiopathic pulmonary fibrosis","volume":"13","author":"Bousamaki","year":"2025","journal-title":"Physiol. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3899\/jrheum.170553","article-title":"The crescentic implication of renal outcomes in proliferative lupus nephritis","volume":"45","author":"Cai","year":"2018","journal-title":"J. Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12964-020-00605-x","article-title":"The diabetic microenvironment causes mitochondrial oxidative stress in glomerular endothelial cells and pathological crosstalk with podocytes","volume":"18","author":"Casalena","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.trsl.2022.03.004","article-title":"Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis","volume":"245","author":"Caza","year":"2022","journal-title":"Transl. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1176619","DOI":"10.3389\/fimmu.2023.1176619","article-title":"The chemokine landscape: one system multiple shades","volume":"14","author":"Cecchinato","year":"2023","journal-title":"Front. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1182\/blood-2015-02-628677","article-title":"Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy","volume":"126","author":"Cho","year":"2015","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2025-006194","article-title":"Treatment with caspase-1 inhibitor diminishes kidney disease in MRL-fas(lpr) mice and delays systemic illness","volume":"11","author":"Cla\u00dfen","year":"2025","journal-title":"RMD Open"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9891","DOI":"10.1038\/s41598-026-35923-6","article-title":"Integration of intragraft transcriptomics and urinary cytokines identifies CXCL10 and FasL signature in subclinical acute rejection","volume":"16","author":"Cox","year":"2026","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imr.12757","article-title":"Exploring the complex role of chemokines and chemoattractants in vivo on leukocyte dynamics","volume":"289","author":"David","year":"2019","journal-title":"Immunol. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1053\/j.ajkd.2025.08.016","article-title":"A change is gonna come to treatment of lupus nephritis: a review","volume":"87","author":"Desai","year":"2026","journal-title":"Am. J. Kidney Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13287-026-05030-4","article-title":"Induction of fibrosis in human kidney organoids delineates mechanisms and therapeutic targets of fibrotic kidney disease","volume":"17","author":"Doeser","year":"2026","journal-title":"Stem Cell Res. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.expneurol.2017.02.012","article-title":"Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"292","author":"Dong","year":"2017","journal-title":"Exp. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/biomedicines14030567","article-title":"Serum levels of selected chemokines in patients with systemic lupus erythematosus correlate with disease activity and clinical features: results from a single-center observational study","volume":"14","author":"Dziedzic","year":"2026","journal-title":"Biomedicines"},{"key":"B22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41598-021-04098-7","article-title":"CCR2 promotes monocyte recruitment and intestinal inflammation in mice lacking the interleukin-10 receptor","volume":"12","author":"El","year":"2022","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00467-023-06051-4","article-title":"Immune urinary biomarkers predict infant cardiac surgery-associated acute kidney injury","volume":"39","author":"Erez","year":"2024","journal-title":"Pediatr. Nephrol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6194864","DOI":"10.1155\/2020\/6194864","article-title":"Role of chemokine (C-X-C motif) ligand 10 (CXCL10) in renal diseases","volume":"2020","author":"Gao","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"B25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40744-023-00623-4","article-title":"Real-world burden of immunosuppressant-treated lupus nephritis: a German claims database analysis","volume":"11","author":"Garal-Pantaler","year":"2024","journal-title":"Rheumatol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/stcltm\/szad069","article-title":"T-Cell mediated immune rejection of Beta-2-Microglobulin knockout induced pluripotent stem cell-derived kidney organoids","volume":"13","author":"Gaykema","year":"2024","journal-title":"Stem Cells Transl. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000553059","article-title":"Kidney organoids: disease modeling and clinical implementations for patient benefit","author":"Gessaroli","year":"2026","journal-title":"Nephron"},{"key":"B28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1124\/mol.108.045146","article-title":"Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events","volume":"74","author":"Gouwy","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"110520","DOI":"10.1016\/j.jbc.2025.110520","article-title":"TET2 has endothelial-specific roles in interferon responses that are dysregulated by hyperglycemia in vitro and in vivo","volume":"301","author":"Green","year":"2025","journal-title":"J. Biol. Chem."},{"key":"B30","first-page":"967","article-title":"The chemokines and their receptors: characteristics and physiological functions","volume":"24","author":"Guerreiro","year":"2011","journal-title":"Acta Med. Port."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1128\/IAI.00129-12","article-title":"Campylobacter jejuni-mediated induction of CC and CXC chemokines and chemokine receptors in human dendritic cells","volume":"80","author":"Hu","year":"2012","journal-title":"Infect. Immun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-025-02533-1","article-title":"Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications","volume":"25","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1620\/tjem.228.17","article-title":"Melanoma differentiation-associated gene 5 regulates the expression of a chemokine CXCL10 in human mesangial cells: implications for chronic inflammatory renal diseases","volume":"228","author":"Imaizumi","year":"2012","journal-title":"Tohoku J. Exp. Med."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/procel\/pwaf020","article-title":"Neutrophil extracellular traps license macrophage production of chemokines to facilitate CD8+ T cell infiltration in obstruction-induced renal fibrosis","author":"Jia","year":"2025","journal-title":"Protein Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cyto.2013.03.016","article-title":"Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis","volume":"62","author":"Kanapathippillai","year":"2013","journal-title":"Cytokine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"773","DOI":"10.18553\/jmcp.2024.23324","article-title":"Evaluating the cost-effectiveness of voclosporin for the treatment of lupus nephritis in the United States","volume":"30","author":"Kennedy","year":"2024","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"B37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1574888X13666181105145144","article-title":"Stem cell-mediated angiogenesis in tissue engineering constructs","volume":"14","author":"Kiaie","year":"2019","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1124\/mol.118.115329","article-title":"Atypical chemokine receptor 3 (ACKR3): a comprehensive overview of its expression and potential roles in the immune system","volume":"96","author":"Koenen","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11906-022-01206-4","article-title":"Inflammation, lymphatics, and cardiovascular disease: amplification by chronic kidney disease","volume":"24","author":"Kon","year":"2022","journal-title":"Curr. Hypertens. Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.3390\/cancers17142335","article-title":"Spatial proximity of immune cell pairs to cancer cells in the tumor microenvironment as biomarkers for patient stratification","volume":"17","author":"Li","year":"","journal-title":"Cancers (Basel)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2521457","DOI":"10.1080\/0886022x.2025.2521457","article-title":"Kidney diseases and single-cell sequencing research: a bibliometric analysis from 2015 to 2024","volume":"47","author":"Li","year":"","journal-title":"Ren. Fail"},{"key":"B42","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s12672-026-04522-2","article-title":"CXCL1 as a novel prognostic biomarker and immune regulator in Colon adenocarcinoma","volume":"17","author":"Li","year":"2026","journal-title":"Discov. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12026-012-8313-7","article-title":"The biology of chemokines and their receptors","volume":"54","author":"Lira","year":"2012","journal-title":"Immunol. Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3892\/mmr.2023.13091","article-title":"Immune podocytes in the immune microenvironment of lupus nephritis (review)","volume":"28","author":"Liu","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0178352","DOI":"10.1371\/journal.pone.0178352","article-title":"CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy","volume":"12","author":"Lu","year":"2017","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"qiaf013","DOI":"10.1093\/jleuko\/qiaf013","article-title":"Extended repertoire of CXC chemokines acting as agonists and antagonists of the human and murine atypical chemokine receptor ACKR2","volume":"117","author":"Lu\u00eds","year":"2025","journal-title":"J. Leukoc. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1681\/ASN.2017050523","article-title":"Exosomal CCL2 from tubular epithelial cells is critical for albumin-induced tubulointerstitial inflammation","volume":"29","author":"Lv","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000545989","article-title":"The relationship between renal interstitial vasculopathy and clinical and prognosis of patients with lupus nephritis","volume":"11","author":"Ma","year":"2025","journal-title":"Kidney Dis. (Basel)."},{"key":"B49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/15548627.2025.2581212","article-title":"CircAASS alleviates renal injury and fibrosis by regulating mitochondrial homeostasis in tubular epithelial cells","volume":"22","author":"Ma","year":"2026","journal-title":"Autophagy"},{"key":"B50","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1002\/jcp.27669","article-title":"Interaction between mesenchymal stromal cell-derived extracellular vesicles and immune cells by distinct protein content","volume":"234","author":"Mardpour","year":"2019","journal-title":"J. Cell Physiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1577201","DOI":"10.3389\/fphar.2025.1577201","article-title":"Albiflorin inhibits inflammation to improve liver fibrosis by targeting the CXCL12\/CXCR4 axis in mice","volume":"16","author":"Meng","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3390\/ijms18102088","article-title":"Chemokines from a structural perspective","volume":"18","author":"Miller","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/acr.22651","article-title":"Validation of the lupus nephritis clinical indices in childhood-onset systemic lupus erythematosus","volume":"68","author":"Mina","year":"2016","journal-title":"Arthritis Care Res. Hob."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","article-title":"CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8(+) T cell antitumor immunity","volume":"56","author":"Moreno Ayala","year":"2023","journal-title":"Immunity"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1391218","DOI":"10.3389\/fimmu.2024.1391218","article-title":"Applying 12 machine learning algorithms and Non-negative Matrix Factorization for robust prediction of lupus nephritis","volume":"15","author":"Mou","year":"2024","journal-title":"Front. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"A538","DOI":"10.1016\/j.jval.2014.08.1722","article-title":"Burden of Lupus Nephritis (Ln) among patients managed in routine clinical practices in Europe (Eu)","volume":"17","author":"Narayanan","year":"2014","journal-title":"Value Health"},{"key":"B57","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fimmu.2012.00266","article-title":"Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines","volume":"3","author":"Novitzky-Basso","year":"2012","journal-title":"Front. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"850998","DOI":"10.3389\/fimmu.2022.850998","article-title":"Role of the CXCL13\/CXCR5 axis in autoimmune diseases","volume":"13","author":"Pan","year":"2022","journal-title":"Front. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00005-022-00646-9","article-title":"Treat-to-Target in lupus nephritis. What is the role of the repeat kidney Biopsy?","volume":"70","author":"Parodis","year":"2022","journal-title":"Arch. Immunol. Ther. Exp. Warsz."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e72644","DOI":"10.7759\/cureus.72644","article-title":"Navigating lupus nephritis: a comprehensive review of the current treatment trends","volume":"16","author":"Patel","year":"2024","journal-title":"Cureus"},{"key":"B61","doi-asserted-by":"publisher","first-page":"vkag100","DOI":"10.1093\/jimmun\/vkag100","article-title":"Longitudinal multiomic and spatial transcriptomic profiling of lupus nephritis progression in a murine model","volume":"215","author":"Patino-Martinez","year":"2026","journal-title":"J. Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1080\/17425255.2020.1801633","article-title":"Albumin-based drug designs for pharmacokinetic modulation","volume":"16","author":"Pilati","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41927-021-00178-3","article-title":"Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis","volume":"5","author":"Pohlmeyer","year":"2021","journal-title":"BMC Rheumatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.celrep.2017.04.078","article-title":"Chemokine signaling and the regulation of bidirectional leukocyte migration in interstitial tissues","volume":"19","author":"Powell","year":"2017","journal-title":"Cell Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1459241","DOI":"10.3389\/fimmu.2024.1459241","article-title":"Successful management of belimumab after obinutuzumab in a patient with systemic lupus erythematosus: a case report with an 18-month follow-up","volume":"15","author":"Pu","year":"2024","journal-title":"Front. Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/hep.31108","article-title":"Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study","volume":"72","author":"Ratziu","year":"2020","journal-title":"Hepatology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3390\/mi14091740","article-title":"Bronchoalveolar lavage fluid from chronic obstructive pulmonary disease patients increases neutrophil chemotaxis measured by a microfluidic platform","volume":"14","author":"Ren","year":"2023","journal-title":"Micromachines (Basel)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3390\/cells13242058","article-title":"The chemokine system as a key regulator of pulmonary fibrosis: converging pathways in human idiopathic pulmonary fibrosis (IPF) and the bleomycin-induced lung fibrosis model in mice","volume":"13","author":"Russo","year":"2024","journal-title":"Cells"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1271\/bbb.120347","article-title":"Advanced glycation endproducts stimulate renal epithelial cells to release chemokines that recruit macrophages, leading to renal fibrosis","volume":"76","author":"Sasai","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/1753425910388833","article-title":"CXC chemokine ligand 4 (CXCL4) down-regulates CC chemokine receptor expression on human monocytes","volume":"18","author":"Schwartzkopff","year":"2012","journal-title":"Innate Immun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.3390\/cancers17243892","article-title":"The rise of fine-tuned CAR-based therapies against acute myeloid leukemia","volume":"17","author":"Segura Tudela","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jid.2017.08.041","article-title":"Toll-like receptor-mediated upregulation of CXCL16 in psoriasis orchestrates neutrophil activation","volume":"138","author":"Steffen","year":"2018","journal-title":"J. Invest. Dermatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"105639","DOI":"10.1016\/j.biocel.2019.105639","article-title":"The effect of core fucosylation-mediated regulation of multiple signaling pathways on lung pericyte activation and fibrosis","volume":"117","author":"Sun","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/14397595.2015.1060665","article-title":"Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy","volume":"26","author":"Tanaka","year":"2016","journal-title":"Mod. Rheumatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e14427","DOI":"10.1111\/nep.14427","article-title":"Lupus nephritis and chronic kidney disease: a scoping review","volume":"30","author":"Teoh","year":"2025","journal-title":"Nephrol. Carlt."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.4049\/jimmunol.178.3.1819","article-title":"C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia\/reperfusion","volume":"178","author":"Thurman","year":"2007","journal-title":"J. Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1078607","DOI":"10.3389\/fpsyt.2023.1078607","article-title":"Mouse models, antibodies, and neuroimaging: current knowledge and future perspectives in neuropsychiatric systemic lupus erythematosus (NPSLE)","volume":"14","author":"Tomalla","year":"2023","journal-title":"Front. Psychiatry"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1005256","DOI":"10.1371\/journal.ppat.1005256","article-title":"Distinct upstream role of type I IFN signaling in hematopoietic stem cell-derived and epithelial resident cells for concerted recruitment of Ly-6Chi monocytes and NK cells via CCL2-CCL3 Cascade","volume":"11","author":"Uyangaa","year":"2015","journal-title":"PLoS Pathog."},{"key":"B79","doi-asserted-by":"publisher","first-page":"101337","DOI":"10.1016\/j.trim.2020.101337","article-title":"Mechanisms underlying the production of chemokine CXCL11 in the reaction of renal tubular epithelial cells with CD4(+) and CD8(+) T cells","volume":"65","author":"Wang","year":"2021","journal-title":"Transpl. Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e20211631","DOI":"10.1084\/jem.20211631","article-title":"CCR2\/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma","volume":"219","author":"Wang","year":"2022","journal-title":"J. Exp. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2644681","DOI":"10.1080\/19490976.2026.2644681","article-title":"Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host","volume":"18","author":"Wang","year":"2026","journal-title":"Gut Microbes"},{"key":"B82","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40164-025-00679-8","article-title":"Recent advances and challenges of cellular immunotherapies in lung cancer treatment","volume":"14","author":"Yang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"F459","DOI":"10.1152\/ajprenal.00146.2014","article-title":"Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors","volume":"308","author":"Yuan","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1128393","DOI":"10.3389\/fmed.2023.1128393","article-title":"Molecular insight in intrarenal inflammation affecting four main types of cells in nephrons in IgA nephropathy","volume":"10","author":"Zhang","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e001578","DOI":"10.1136\/lupus-2025-001578","article-title":"Total tubulointerstitial score: a simple and effective predictor of long-term mortality and adverse renal outcomes in lupus nephritis","volume":"12","author":"Zhang","year":"2025","journal-title":"Lupus Sci. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.7150\/thno.124358","article-title":"Searching for a HIV-1 cure","volume":"16","author":"Zhang","year":"2026","journal-title":"Theranostics"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/art.42492","article-title":"Ezh2 knockout in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in MRL\/Lpr mice","volume":"75","author":"Zheng","year":"2023","journal-title":"Arthritis Rheumatol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1867426\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:36:31Z","timestamp":1785821791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1867426\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":87,"alternative-id":["10.3389\/fphar.2026.1867426"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1867426","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"article-number":"1867426"}}